Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Clinical Data, Inc. - CLDA
22 Fevereiro 2011 - 7:34PM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of Clinical Data, Inc. (“Clinical Data” or the “Company”)
(NasdaqGM: CLDA) for potential breaches of fiduciary duties in
connection with their conduct related to the sale of the Company to
Forest Laboratories, Inc. (NYSE: FRX) for at least $1.2 billion in
a tender offer. The proposed transaction offers Clinical Data
shareholders $30 per share in cash and a contingent consideration
of up to $6 per share if the Company’s newly approved
antidepressant Viibryd helps offset the loss of major products in
coming years. The deal is structured as a tender offer, which may
avoid the need for a shareholder vote, and is expected to close in
the second quarter of 2011.
Request more information now by clicking here:
www.faruqilaw.com/CLDA.
Whether the Clinical Data’s Board of Directors breached their
fiduciary duties to Clinical Data’s stockholders by failing to
conduct an adequate and fair sales process to sell the Company
prior to agreeing to this proposed transaction, whether the
proposed transaction undervalues Clinical Data’s shares and by how
much this proposed transaction undervalues the Company to the
detriment of Clinical Data shareholders are the key focus of this
investigation.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, through all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in Clinical Data and wish to obtain
additional information, please visit us at www.faruqilaw.com/CLDA
or contact Juan E. Monteverde, Esq. either via e-mail at
jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or
(212) 983-9330.
Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Clinical Data (NASDAQ:CLDA)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Clinical Data (NASDAQ:CLDA)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Clinical Data, Inc. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Faruqi & Faruqi, LLP